/
Markets
Crypto
News
Forecasts
Forex Brokers
Calendars
Macro Data
About us
Commodity Prices
Currency Rates
Cryptocurrency Prices
Global Market Indices
Stock Prices
ETF Prices
Cryptocurrency Prices
Crypto Exchanges
Crypto Wallets
Cryptocurrency News
Cryptocurrency Forecasts
Commodity News
Forex News
Crypto News
Stock Market News
Economic News
Opinions
Broker News
Commodities
Forex
Crypto
Indices
Natural Gas Forecasts
Gold Forecasts
WTI Crude Oil Forecasts
S&P 500 Forecasts
Forex Brokers Reviews
Best Brokers Guides
Compare Forex Brokers
Best Forex Brokers
Best Forex Platforms
Best MT4 Brokers
Best for Trading Gold
Best Brokers in Australia
Best Brokers for Beginners
Best Brokers in UK
Stock Brokers
Economic Calendar
Earnings Calendar
Splits Calendar
Dividends Calendar
Holiday Calendar
IPO Calendar
Stock Screener
Currency Converter
Global Macro indicators
Sovereign Credit Ratings
Global Major Indicators
Interest Rates
United States Indicators
China Indicators
Australia Indicators
Euro Area Indicators
About us
Contact Us
Terms Of Use
Become A Contributer
EUR/USD
+0.08%
Natural Gas
-0.35%
Gold
N/A
BTC
N/A
ETH
N/A
SPX
-0.02%
VIX
N/A
Economic Calendar
EUR/USD
+0.08%
Natural Gas
-0.35%
Gold
N/A
BTC
N/A
ETH
N/A
SPX
-0.02%
VIX
N/A
Economic Calendar
BTC
N/A
ETH
N/A
XRP
N/A
ADA
N/A
SOL
N/A
Review
Review
Review
China Economy Grows by 4.6% in Q3 2024 as Markets Clamor for More Stimulus
about 1 hour ago
Netflix Stock Rises 4% on Q3 Beat, TSMC Posts 54% Profit Surge as AI Drives Growth
about 6 hours ago
Crude Inventories Decline By 2.2 Million Barrels, Missing Analyst Expectations
about 12 hours ago
EIA Natural Gas Storage Build Of +76 Bcf Misses Analyst Estimates
about 12 hours ago
U.S. Retail Sales Surge 0.4% in September, Led by E-Commerce Growth
about 14 hours ago
ECB Slashes Rates to 3.25%, Signals More Easing Amid Weak Growth
about 15 hours ago
Gold, EUR/USD, US Dollar Technical Analysis After Strong US Retail Sales
about 3 hours ago
XRP News Today: Did the SEC Miss Ripple Appeal Deadline? BTC-Spot ETF Inflows Surge
about 3 hours ago
Japanese Yen and Australian Dollar News: Japan Inflation and China GDP in Focus
about 5 hours ago
Crude Oil Price Forecast: Near Key Support, Eyes Potential Bullish Reversal
about 7 hours ago
Gold Price Forecast: Breaks Record High, Bullish Momentum Continues
about 7 hours ago
Natural Gas Price Forecast: Faces Key Support as Downtrend Continues
about 7 hours ago
Quick Links
:
Forecasts
Economic Calendar
Commodities
Trade Now
ad
ad
Advertisement
Advertisement
home
stocks
AZN
profile
Astrazeneca plc - ADR
Follow
AZN
(
Nasdaq - US
)
Closed
78.03
-0.28 (-0.36%)
in
:
usd
•
As of: Oct 17, 2024 15:59
UTC -4
After Market
:
77.91
-0.12 (-0.15%)
Open
77.98
High
78.38
Low
77.88
Overview
News & Analysis
Profile
Financials
Advanced Chart
History
Earnings
Dividends
About
Astrazeneca plc - ADR
CEO
Pascal Soriot
Headquarters
1 francis crick avenue, cambridge biomedical campus
cambridge, x0 cb2 0aa, united kingdom
Auditor
PricewaterhouseCoopers LLP
Employees
89,900
Share Holders
N/A
Website
www.astrazeneca.com
Industry
pharmaceuticals major
Sector
health technology
Company Overview
AstraZeneca plc, is one of the largest biopharmaceutical companies in the world. AstraZeneca's business can be broken down into separate lines based on therapeutic classes. These include cardiovascular, respiratory, immunology, oncology, rare diseases and other.In July 2021 AstraZeneca closed the acquisition of rare disease drugmaker, Alexion. The acquisition added Alexion's five marketed rare disease products and its pipeline of immune-mediated rare disease candidates.In order to bolster its respiratory portfolio, AstraZeneca acquired rights to Allergan's branded respiratory business in the U.S. and Canada in Mar 2015. The company also acquired Takeda's core respiratory business in May 2016.In June 2007, AstraZeneca acquired biotechnology company MedImmune. In Aug 2011, AstraZeneca sold its Astra Tech business to DENTSPLY. AstraZeneca entered into a number of deals and struck agreements with companies such as FibroGen and Daiichi Sankyo.
Astrazeneca plc - ADR
Statistics
Valuation Measures
Market Capitalization
2
241.94B
Enterprise Value
267.31B
Enterprise Value/EBITDA
(ttm)
18.84
Price to Earnings Ratio
(ttm)
21.51
Price to Book
(mrq)
6.10
Price to Sales
(ttm)
4.91
Price to Cash
(ytd)
14.43
Profitability
Gross Margin
(ttm)
82.05%
Operating Margin
(ttm)
22.92%
Profit Margin
(ttm)
13.00%
Return on Equity
(ttm)
29.34%
Return on Invested Capital
(ttm)
10.13%
Return on Assets
(ttm)
11.15%
Income Statement
Revenue
(ttm)
49.13B
Revenue Per Share
(ttm)
N/A
Gross Profit
(ttm)
40.33B
EBITDA
(ttm)
3
14.19B
Net Income Avi to Common
(ttm)
6.44B
Diluted EPS
(ttm)
2.07
Share Statistics
Beta (5Y Monthly)
0.46
52-Week Change
22.19%
S&P500 52-Week Change
33.57%
S&P500 Member
No
Stock Optionable
Yes
Total Shares Outstanding
1
N/A
Dividend Yield
1.26%
Float
4
0.00
%
Held by Insiders
N/A
%
Held by Institutions
20.35%
Balance Sheet
Total Cash
(mrq)
7.10B
Total Cash Per Share
(mrq)
N/A
Total Debt
(mrq)
32.29B
Total Debt/Equity
(mrq)
81.55%
Current Ratio
(mrq)
0.89%
Quick Ratio
(mrq)
0.69%
Book Value Per Share
(mrq)
N/A
Cash Flow
Operating Cash Flow Per Share
(ytd)
1.79
Free Cash Flow
(ytd)
4.83B
Table Key
mrq
=
Most Recent Quarter
ttm
=
Trailing Twelve Months
ytd
=
Year To Date
Footnotes
Data provided by Zacks Investment Research or calculated by FXEmpire. Stock price provided by Xignite. All numbers are rounded to the closest decimal.
1
Total Shares outstanding is taken from the most recently filed quarterly or annual report.
2
Market Cap is calculated using total shares outstanding and the most recent share price.
3
EBITDA is calculated using methodology that may differ from that used by a company in its reporting.
4
The float is a measure of the number of shares available for trading by the public. It's calculated by taking the number of issued and outstanding shares minus any restricted stock, which might not be publicly traded.
Sponsored
Sponsored
This Section / Page contains links to the 3rd party websites of our top partners from whom we may receive compensation.
Trade With A Regulated Broker